Trial
NCT02133183
Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Glioblastoma
Intervention
Laboratory Biomarker Analysis
Why stopped
Other - Lapse in funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-04